US9205062B2 - Transdermal systems containing multilayer adhesive matrices to modify drug delivery - Google Patents

Transdermal systems containing multilayer adhesive matrices to modify drug delivery Download PDF

Info

Publication number
US9205062B2
US9205062B2 US12/272,706 US27270608A US9205062B2 US 9205062 B2 US9205062 B2 US 9205062B2 US 27270608 A US27270608 A US 27270608A US 9205062 B2 US9205062 B2 US 9205062B2
Authority
US
United States
Prior art keywords
drug
adhesive
delivery
anti
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US12/272,706
Other versions
US20090142390A1 (en
Inventor
Kristin Jackson
II Kenneth J. Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Pharmaceuticals Inc
Original Assignee
Mylan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/795,584 priority Critical patent/US20050202073A1/en
Priority to PCT/US2005/005223 priority patent/WO2005091852A2/en
Application filed by Mylan Pharmaceuticals Inc filed Critical Mylan Pharmaceuticals Inc
Priority to US12/272,706 priority patent/US9205062B2/en
Assigned to MYLAN PHARMACEUTICALS, INC. reassignment MYLAN PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JACKSON, KRISTIN, MILLER, II, KENNETH J.
Publication of US20090142390A1 publication Critical patent/US20090142390A1/en
Assigned to JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT reassignment JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT SECURITY AGREEMENT Assignors: DEY PHARMA, L.P., DEY, INC., MYLAN INC., MYLAN PHARMACEUTICALS INC., MYLAN TECHNOLOGIES, INC.
Assigned to MYLAN PHARMACEUTICALS, INC., DEY PHARMA, L.P. (F/K/A DEY, L.P.), MYLAN INC., MYLAN TECHNOLOGIES, INC. reassignment MYLAN PHARMACEUTICALS, INC. PATENT RELEASE Assignors: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Assigned to BANK OF AMERICA, N.A., AS COLLATERAL AGENT reassignment BANK OF AMERICA, N.A., AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: DEY PHARMA, L.P. (F/K/A DEY L.P.), MYLAN BERTEK PHARMACEUTICALS INC., MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.), MYLAN PHARMACEUTICALS, INC., MYLAN TECHNOLOGIES, INC., SOMERSET PHARMACEUTICALS, INC.
Assigned to MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.), MYLAN PHARMACEUTICALS, INC., MYLAN INC., MYLAN BERTEK PHARMACEUTICALS INC., DEY PHARMA L.P. (F/K/A DEY, L.P.), SOMERSET PHARMACEUTICALS, INC., MYLAN TECHNOLOGIES, INC. reassignment MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.) PATENT RELEASE Assignors: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Publication of US9205062B2 publication Critical patent/US9205062B2/en
Application granted granted Critical
Application status is Active legal-status Critical
Adjusted expiration legal-status Critical

Links